Net Cash Provided by (Used in) Operating Activities |
-725K |
USD |
+21.4% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
856K |
USD |
-62.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-57.1K |
USD |
-49.6% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
50M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
14.4M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
77.5K |
USD |
-94.2% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
355K |
USD |
-19.2% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Dec 31, 2023 |
Q4 2023 |
Depreciation |
161 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
32K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-355K |
USD |
+35.2% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
355K |
USD |
-19.2% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-332K |
USD |
+35.2% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
5M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
12.7M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
1.75M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
-22.8K |
USD |
+35.2% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
566K |
USD |
+208% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Mar 31, 2024 |
Q1 2024 |